REG - BlackRock Group Medtronic, Inc. - Form 8.3 - Medtronic, Inc. <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 0221WBlackRock Group03 November 2014Ap19
FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)
BlackRock, Inc.
Companydealtin
Medtronic, Inc.
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
$0.10 common shares
Dateofdealing
31 October 2014
2. INTERESTSANDSHORTPOSITIONS
(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
60,360,314 (6.14%)
51,058 (0.00%)
(2)Derivatives(otherthanoptions)
973 (0.00%)
11,267 (0.00%)
(3)Optionsandagreementstopurchase/sell
0 (0.00%)
69,300 (0.00%)
Total
60,361,287 (6.14%)
131,625 (0.01%)
(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)
Classofrelevantsecurity:
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
(2)Derivatives(otherthanoptions)
(3)Optionsandagreementstopurchase/sell
Total
Ap20
1. DEALINGS(Note4)
(a) Purchasesandsales
Purchase/sale
Numberofrelevantsecurities
Priceperunit(Note5)
Purchase
31,398
USD 68.1569
Purchase
38,952
USD 68.1576
Purchase
18,378
USD 68.1600
Purchase
479
USD 68.1600
Sale
54,300
USD 67.9969
Sale
600
USD 68.0531
Sale
789
USD 68.1230
Sale
81,100
USD 68.1473
Sale
8,595
USD 68.1600
Sale
219
USD 68.2202
Please note: there was also a Transfer Out of 59,859 Shares
(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note6)
Numberofrelevantsecurities
(Note7)
Priceperunit
(Note5)
CFD
Reducing Short
40
USD 68.2600
(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note5)
(ii) Exercising
Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note5)
(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)
Natureoftransaction
(Note8)
Details
Priceperunit
(if applicable) (Note 5)
Ap21
2. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosingandanyotherpersonrelatingtothevotingrightsofanyrelevant
securitiesunderanyoptionreferredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofanyrelevantsecuritiestowhichany
derivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.
None
IsaSupplementalForm8attached?(Note9) YES
Dateofdisclosure
03 November 2014
Contactname
Gareth Slade
Telephonenumber
+44 20 7743 2536
IfaconnectedEFM,nameofofferee/offerorwithwhichconnected
IfaconnectedEFM,statenatureofconnection(Note10)
Ap23
SUPPLEMENTALFORM8
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.1ANDRULE8.3OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013
DETAILSOFOPENPOSITIONS
(ThisformshouldbeattachedtoForm8.1(a)&(b)(i),Form8.1(b)(ii)orForm8.3,asappropriate)
OPENPOSITIONS(Note1)
Productname,
e.g.calloption
Written,orpurchased
Numberofrelevant securitiestowhichtheoptionorderivativerelates
Exercise price(Note2)
Type,e.g.American,Europeanetc.
Expiry date
Call Option
Written
21,100
USD 65.50
American
07/11/2014
Call Option
Written
12,500
USD 66.00
American
14/11/2014
Call Option
Written
35,700
USD 66.50
American
14/11/2014
Notes
1.Wherethereareopenoptionpositionsoropenderivativepositions(exceptforCFDs),fulldetailsshouldbegiven.Fulldetailsofanyexisting
agreementstopurchaseortosellmust alsobegivenonthisform.
2. Forallpricesandothermonetaryamounts, thecurrencymust bestated.
Forfulldetailsofdisclosurerequirements,seeRule8oftheRules.Ifindoubt,consultthePanel.
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEUOUVRSRAARAA
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement